Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-6641.96%
operating margin TTM
-7112.72%
revenue TTM
726.63 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -3.05 |
| peg ratio | 0.72 |
| price to book ratio | 1.67 |
| price to sales ratio | 282.53 |
| enterprise value multiple | -5.04 |
| price fair value | 1.67 |
profitability ratios | |
|---|---|
| gross profit margin | 69.74% |
| operating profit margin | -7112.72% |
| pretax profit margin | -6642.84% |
| net profit margin | -6641.96% |
| return on assets | -46.74% |
| return on equity | -73.98% |
| return on capital employed | -58.08% |
liquidity ratio | |
|---|---|
| current ratio | 7.08 |
| quick ratio | 7.08 |
| cash ratio | 3.83 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 412.49 |
| days of payables outstanding | 8,500.80 |
| cash conversion cycle | -8,088.30 |
| receivables turnover | 0.88 |
| payables turnover | 0.04 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -24.75 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.79 |
| cash per share | 1.93 |
| operating cash flow per share | -0.79 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -24.75 |
| short term coverage ratios | -53.09 |
| capital expenditure coverage ratio | -471.16 |
Frequently Asked Questions
When was the last time Cardiff Oncology, Inc. (NASDAQ:CRDF) reported earnings?
Cardiff Oncology, Inc. (CRDF) published its most recent earnings results on 07-11-2024.
What is Cardiff Oncology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Cardiff Oncology, Inc. (NASDAQ:CRDF)'s trailing twelve months ROE is -73.98%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Cardiff Oncology, Inc. (CRDF) currently has a ROA of -46.74%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CRDF's net profit margin stand at?
CRDF reported a profit margin of -6641.96% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CRDF's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.08 in the most recent quarter. The quick ratio stood at 7.08, with a Debt/Eq ratio of 0.02.